Non-ownership Filings
Total Voting Rights | Sep. 01, 2025 |
Total Voting Rights | Aug. 01, 2025 |
H1 and Q2 2025 results | Jul. 29, 2025 |
Gefurulimab nanobody met Phase III endpoints | Jul. 24, 2025 |
AstraZeneca plans to invest $50bn in the US | Jul. 22, 2025 |
Update on anselamimab in AL amyloidosis | Jul. 16, 2025 |
Baxdrostat met primary endpt in BaxHTN PhIII trial | Jul. 14, 2025 |
Ownership Update Filings
Holding(s) in Company | Aug. 28, 2025 |
Holding(s) in Company | Aug. 26, 2025 |
Holding(s) in Company | Aug. 21, 2025 |
Director/PDMR Shareholding | Aug. 18, 2025 |
Holding(s) in Company | Aug. 15, 2025 |
Holding(s) in Company | Aug. 12, 2025 |
Director/PDMR Shareholding | Jun. 12, 2025 |